← Leaderboards
Shelli R Kesler
Virginia Commonwealth University
$7,903,167
Attributed
$11,865,903
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2008–24$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,865,903 · 9
By mechanism
R01$8,284,533 · 3
DP2$2,400,000 · 1
K07$822,881 · 1
R03$334,126 · 2
P41$24,363 · 2
Top collaborators
- Oxana G Palesh14 shared
- Jeffrey Scott Wefel5 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Arun J Sanyal$37,042,537
- William Gregory Hundley$19,718,962
- Kenneth Seedman Kendler$36,426,058
- Kristina Sundquist$9,160,165
- Michael C. Neale$26,862,438
Others in their field
Top investigators on “Neuroimaging”
- Michael W Weiner · Northern California Institute Res &Educ$161,074,866
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,102,078
- David R. Weir · University Of Michigan At Ann Arbor$109,946,166
- Paul S. Aisen · Cognition Therapeutics, Inc.$109,939,721
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$106,631,927
- Arthur W Toga · University Of Southern California$93,816,501
Research focus
NeuroimagingBrainChemotherapyImpairmentImpaired CognitionFemaleDisabilityCognitiveMagnetic Resonance ImagingChemotherapy-Oncologic ProcedureAffectCognitive DeficitsWomanMalignant Breast NeoplasmQuality Of LifeMemoryStructureIncidenceAttentionLifeMalignant NeoplasmsNeuropsychologicalExecutive FunctionOperative Surgical Procedures
Grant awards (33)
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$488,028
R01 · FY2024 · CA · contact PI
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)$312,611
R01 · FY2024 · CA
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$500,546
R01 · FY2023 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$535,294
R01 · FY2022 · CA · contact PI
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$135,815
R01 · FY2022 · CA
Using Connectomics and Machine Learning to Predict Survival in Diffuse Glioma$81,045
R03 · FY2022 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$281,784
R01 · FY2021 · CA · contact PI
Using Connectomics and Machine Learning to Predict Survival in Diffuse Glioma$93,081
R03 · FY2021 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$612,633
R01 · FY2020 · CA · contact PI
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$335,114
R01 · FY2020 · CA
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$645,700
R01 · FY2019 · CA · contact PI
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$338,233
R01 · FY2019 · CA
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$287,435
R01 · FY2019 · CA
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer$395,201
R01 · FY2017 · NR
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer$496,400
R01 · FY2016 · NR
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$325,775
R01 · FY2016 · CA
Machine Learning Comparison of Brain Anatomy in Cancer and Alzheimer's Disease$80,000
R03 · FY2016 · CA · contact PI
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$325,775
R01 · FY2015 · CA
Machine Learning Comparison of Brain Anatomy in Cancer and Alzheimer's Disease$80,000
R03 · FY2015 · CA · contact PI
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer$529,314
R01 · FY2014 · NR
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$316,002
R01 · FY2014 · CA
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer$513,256
R01 · FY2013 · NR
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma$166,757
K07 · FY2013 · CA · contact PI
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$33,286
R01 · FY2013 · CA · contact PI
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer$550,556
R01 · FY2012 · NR
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$325,775
R01 · FY2012 · CA · contact PI
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma$166,892
K07 · FY2012 · CA · contact PI
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma$166,958
K07 · FY2011 · CA · contact PI
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma$163,040
K07 · FY2010 · CA · contact PI
TURNER SYNDROME: LINKING GENES, BRAIN AND BEHAVIOR$12,333
P41 · FY2010 · RR · contact PI
Neurobiologic Mechanisms of Cognitive Dysfunction and Decline in Medulloblastoma$159,234
K07 · FY2009 · CA · contact PI
TURNER SYNDROME: LINKING GENES, BRAIN AND BEHAVIOR$12,030
P41 · FY2009 · RR · contact PI
Assessment and Treatment of Cognitive Deficits in Breast Cancer$2,400,000
DP2 · FY2008 · OD · contact PI